Xingming Deng, MD, PhD


Dr. Deng's research interests are focused on development of new agents and strategies for treatment of lung and head/neck cancers by targeting apoptosis and DNA repair signaling pathways.

Titles and Roles

Associate Professor, Department of Radiation Oncology
Emory University School of Medicine
Research Program
Discovery and Developmental Therapeutics


Dr. Deng holds appointment as Associate Professor in the Department of Radiation Oncology at Emory University School of Medicine. He is also a core member of the Discovery and Developmental Therapeutics Program in the Winship Cancer Institute of Emory University.

He is an active member of the American Association for Cancer Research. He has published more than 73 research articles in peer-reviewed, high quality of journals, including Mol Cell, PNAS, Cancer Res, Cell Death Differ., MCB, Blood, JBC, etc. He has also obtained three patents of new anticancer drug discovery. He has been the recipient of numerous Clinical Innovator Awards from Flight Attendant Medical Research Institute, NASA, and R01 grants from NIH/NCI. Dr. Deng also teaches the advanced course for graduate students. In recent years, Dr. Deng has mentored a number of undergraduates, graduates, postdoctoral fellows and medical resident in cancer research.


Dr. Deng received his MD/PhD at Hunan Medical University and Beijing Medical University in China. He completed his postdoctoral training from University of Texas Medical Branch at Galveston. Dr. Deng came to Emory from University of Florida at which he was an Assistant Professor in Division of Hematology/Oncology, Department of Medicine from 2002 to 2009. l Branch. 1995-1999.

Cascade Link